Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Active Cellular and Subcellular Targeting of Nanoparticles for Drug Delivery
Okhil K. Nag, James B. Delehanty
Pharmaceutics (2019) Vol. 11, Iss. 10, pp. 543-543
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Engineering precision nanoparticles for drug delivery
Michael J. Mitchell, Margaret M. Billingsley, Rebecca M. Haley, et al.
Nature Reviews Drug Discovery (2020) Vol. 20, Iss. 2, pp. 101-124
Open Access | Times Cited: 5155
Advances in nanomaterial-based targeted drug delivery systems
Xiaoxiao Cheng, Qirong Xie, Yang Sun
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 143
The Promise of Nanotechnology in Personalized Medicine
Maha Al‐Ghamdi, Antonino N. Fallica, Nicola Filippo Virzì, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 5, pp. 673-673
Open Access | Times Cited: 123
Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery
Saquib Waheed, Zhibin Li, Fangyingnan Zhang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 111
Nanodrugs alleviate acute kidney injury: Manipulate RONS at kidney
Qiaohui Chen, Yayun Nan, Yuqi Yang, et al.
Bioactive Materials (2022) Vol. 22, pp. 141-167
Open Access | Times Cited: 82
Radiolabeled nanomaterial for cancer diagnostics and therapeutics: principles and concepts
Muskan Goel, Yuri Mackeyev, Sunil Krishnan
Cancer Nanotechnology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 47
Novel super porous nanosponge-based drug delivery system synthesized from cyclodextrin/polymer for anti-fungal medication
Prateep Sengupta, Amrita Das, D. P. Datta, et al.
Reactive and Functional Polymers (2024) Vol. 196, pp. 105830-105830
Closed Access | Times Cited: 15
Mechanistic Understanding From Molecular Dynamics Simulation in Pharmaceutical Research 1: Drug Delivery
Alex Bunker, Tomasz Róg
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 93
Nanotechnology in pulmonary medicine
Mohammad Doroudian, Andrew O’ Neill, Ronan Mac Loughlin, et al.
Current Opinion in Pharmacology (2020) Vol. 56, pp. 85-92
Open Access | Times Cited: 71
Nanoparticles Targeting Receptors on Breast Cancer for Efficient Delivery of Chemotherapeutics
Sulltana Jahan, Md. Emranul Karim, Ezharul Hoque Chowdhury
Biomedicines (2021) Vol. 9, Iss. 2, pp. 114-114
Open Access | Times Cited: 62
Bioinert, Stealth or Interactive: How Surface Chemistry of Nanocarriers Determines Their Fate In Vivo
Julian David Friedl, Valeria Nele, Giuseppe De Rosa, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 34
Open Access | Times Cited: 57
Overview of Physicochemical Properties of Nanoparticles as Drug Carriers for Targeted Cancer Therapy
Vugar Yagublu, Aynura Karimova, Javahir Hajibabazade, et al.
Journal of Functional Biomaterials (2022) Vol. 13, Iss. 4, pp. 196-196
Open Access | Times Cited: 45
Unlocking the Mitochondria for Nanomedicine-based Treatments: Overcoming Biological Barriers, Improving Designs, and Selecting Verification Techniques
Camilla Pegoraro, Inés Domingo-Ortí, Inmaculada Conejos‐Sánchez, et al.
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115195-115195
Open Access | Times Cited: 11
Recent Review on Biological Barriers and Host–Material Interfaces in Precision Drug Delivery: Advancement in Biomaterial Engineering for Better Treatment Therapies
Rohitas Deshmukh, Pranshul Sethi, Bhupendra Singh, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1076-1076
Open Access | Times Cited: 10
An update on strategies for optimizing polymer-lipid hybrid nanoparticle-mediated drug delivery: exploiting transformability and bioactivity of PLN and harnessing intracellular lipid transport mechanism
Taksim Ahmed, Fuh-Ching Franky Liu, Xiao Yu Wu
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 2, pp. 245-278
Closed Access | Times Cited: 8
Delivery of Anti‐microRNA‐712 to Inflamed Endothelial Cells Using Poly(β‐amino ester) Nanoparticles Conjugated with VCAM‐1 Targeting Peptide
Pere Dosta, Ian A. Tamargo, Víctor Ramos, et al.
Advanced Healthcare Materials (2021) Vol. 10, Iss. 15
Open Access | Times Cited: 51
Smart and Multi-Functional Magnetic Nanoparticles for Cancer Treatment Applications: Clinical Challenges and Future Prospects
Elham Aram, Masome Moeni, Roya Abedizadeh, et al.
Nanomaterials (2022) Vol. 12, Iss. 20, pp. 3567-3567
Open Access | Times Cited: 31
Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer
Pourya Sarvari, Pouya Sarvari, Ivonne Ramírez‐Díaz, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9521-9521
Open Access | Times Cited: 30
Targeted systematic evolution of an RNA platform neutralizing DNMT1 function and controlling DNA methylation
Carla Lucia Esposito, Ida Autiero, Annamaria Sandomenico, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Implantable smart hyperthermia nanofibers for cancer therapy: Challenges and opportunities
Amir Valizadeh, Samira Asghari, Saleheh Abbaspoor, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2023) Vol. 15, Iss. 6
Closed Access | Times Cited: 18
State-of-the-Art Review on Inhalable Lipid and Polymer Nanocarriers: Design and Development Perspectives
Gabriella Costabile, Gemma Conte, Susy Brusco, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 347-347
Open Access | Times Cited: 7
Self-assembled dual fluorescence nanoparticles for CD44-targeted delivery of anti-miR-27a in liver cancer theranostics
Xiao Zheng, Fan Zhang, Yawei Zhao, et al.
Theranostics (2018) Vol. 8, Iss. 14, pp. 3808-3823
Open Access | Times Cited: 50
A Nanomedicine Structure–Activity Framework for Research, Development, and Regulation of Future Cancer Therapies
Brian Youden, Runqing Jiang, Andrew Carrier, et al.
ACS Nano (2022) Vol. 16, Iss. 11, pp. 17497-17551
Closed Access | Times Cited: 25
Targeting nanoparticles to malignant tumors
Nikita Sharma, Kais Bietar, Ursula Stochaj
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 3, pp. 188703-188703
Closed Access | Times Cited: 24
Sequential Drug Delivery in Targeted Cancer Therapy
Han Yu, Na Ning, Meng Xi, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 573-573
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top